| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |